BOSTON (Reuters) - Juicing up the body's blood supply with the Johnson & Johnson drug Procrit can reduce the risk of death in critically ill trauma patients by nearly 60 percent, researchers reported on Wednesday.
But the findings, published in the New England Journal of Medicine, are not strong enough to recommend the drug as a routine treatment in hospital intensive care units, other experts said.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!